Advancing cancer immunotherapy through research, collaboration and data-driven innovation. Creating a world #Immune2Cancer. Est. 1953.
New York, NY, USA
Joined April 2008
- Tweets27.1K
- Following4.6K
- Followers30.6K
- Likes14.4K
An incredible evening celebrating #CancerResearch! ✨
Last night, we gathered in NYC for our 2026 Annual Awards Gala to honor those advancing #cancerimmunotherapy, including Reed Jobs, Eric Vivier, DVM, PhD, and Joseph Sun, PhD.
Read the recap: bit.ly/4rZmXox
Cancer Research Institute retweeted
CRI-Funded Research and Scientific Presentations at SITC 2026 – Cancer Research Institute (CRI)
@CancerResearch
oncodaily.com/societies/canc…
During Estate Planning Week, learn how to take the first step toward making your wishes known and leaving a lasting impact on cancer research.
📖 Read more and access our free guide: bit.ly/4ykHNjG
#PlannedGiving #EstatePlanningAwarenessWeek
When caught before it spreads, breast cancer has a 5-year survival rate of over 99%. Mammograms can find it before symptoms appear.
This #NationalMammographyDay, learn 7 screening facts: bit.ly/4zohpGN
#BreastCancerAwareness
Cancer Research Institute retweeted
Looking forward to CRI William B. Coley Award Lecture!
See you in Phoenix!
Heading to #SITC26 in Phoenix, Nov. 4–8? Don't miss CRI's William B. Coley Award Lecture featuring Éric Vivier, plus presentations from CRI-funded scientists advancing #cancerimmunotherapy.
Explore CRI at SITC: bit.ly/3UmhtYJ
#CancerResearch @sitcancer
Heading to #SITC26 in Phoenix, Nov. 4–8? Don't miss CRI's William B. Coley Award Lecture featuring Éric Vivier, plus presentations from CRI-funded scientists advancing #cancerimmunotherapy.
Explore CRI at SITC: bit.ly/3UmhtYJ
#CancerResearch @sitcancer
We’re proud to celebrate our CEO, Alicia Zhou, PhD, named one of @OncoDaily’s 100 Influential #WomenInOncology for 2026! 🎉
Her leadership continues to advance CRI’s mission and champion innovative #cancerimmunotherapy research. bit.ly/4jcwkiA
First diagnosed with stage 0 breast cancer, Judy Perkins later faced stage 4 disease. After receiving tumor-infiltrating lymphocyte (TIL) therapy, she became cancer-free and remains disease-free nearly a decade later. bit.ly/4elv0Gy
#MetastaticBreastCancerAwarenessDay
New research from CRI Irvington Postdoctoral Fellow @vBarthet and his team at @MSKCancerCenter explores a targeted nanotherapy designed to reduce fibrosis and improve response to checkpoint #immunotherapy.
Published in @ScienceMagazine.
Learn more: bit.ly/4hXyX6B
This #DAFDay, make a lasting impact on #cancerresearch.
By recommending a grant to CRI through your #DonorAdvisedFund, you can help advance innovative research and new discoveries in #cancerimmunotherapy.
Learn more: bit.ly/4AJBFnS
As the world celebrates the #NobelPrize, we're reflecting on CRI's history of recognizing groundbreaking science.
12 William B. Coley Award recipients have gone on to win the Nobel Prize.
Meet a few of these scientists and explore their impact. 👉
bit.ly/4rMUceE
This #BreastCancerAwarenessMonth, explore new treatment options, emerging research, and CRI-supported advances: bit.ly/4yZYim3
Cancer Research Institute retweeted
Continuing a special OncoDaily tradition - 𝟭𝟬𝟬 𝗜𝗻𝗳𝗹𝘂𝗲𝗻𝘁𝗶𝗮𝗹 𝗪𝗼𝗺𝗲𝗻 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 - we are proud to present the 6th part of our 2026 list, celebrating the next 10 remarkable women whose leadership and contributions are shaping the future of oncology 🚀
🪄Alicia Zhou, PhD (@ay_zhou) is the Chief Executive Officer of the Cancer Research Institute (@CancerResearch), where she leads efforts to accelerate lifesaving cancer immunotherapy research. A scientist and healthcare executive with experience in cancer research, precision medicine, and health innovation, she has strengthened CRI’s support for investigators pursuing bold and potentially transformative ideas.
In 2026, CRI committed a record $34.4 million through 93 awards – the largest annual grantmaking total in its history – supporting scientists at 50 institutions across five countries. Through this investment, Zhou is helping sustain the research ecosystem behind the next generation of cancer immunotherapies.
Read the 6th part below.
🔗oncodaily.com/100/100-influe…
#Oncology #OncoDaily100 #OncoDaily #Cancer #100InfluentialWomen #WomenInOncology
Meet Reuven Agami, PhD, who is leading the CRI-supported @CancerGrand ILLUMINE team into the "dark proteome," a largely unexplored part of cancer biology.
Their goal: new targets for #immunotherapy in hard-to-treat cancers. bit.ly/3TdZl2L
When LaToya was diagnosed with #breastcancer, she was not offered #immunotherapy as an initial treatment option. After conducting her own research, she enrolled in a lifesaving clinical trial.
Hear her story: bit.ly/3VaXYCs
#BreastCancerAwarenessMonth
🏃 #TeamCRI is hitting the road!
Oct. 4: Cardiff Half Marathon
Oct. 25: Dublin Marathon
Oct. 25: Valencia Half Marathon
Nov. 1: TCS NYC Marathon
Want to join? Request an entry for select races or come cheer on our runners! bit.ly/4rugYrJ
#CancerResearch
🎗️ This #ChildhoodCancerAwarenessMonth, CRI STAR and pediatric oncologist Robbie Majzner, MD, shares what makes childhood cancers different and how #immunotherapy research could lead to new treatments. bit.ly/4jfY6dM
Congratulations, @vBarthet and team! We’re proud to have supported your postdoctoral research and excited to see where this work leads.
Finally out! 🎉 Our new paper @ScienceMagazine on how we can target pathogenic macrophages to break down fibrosis and enhance immunotherapy efficacy in cancer. Huge team effort! Check our thread below 👇
Victoria “Vicky” Ann Michelis did not want ovarian cancer to define her.
Today, one of her best friends, Rob Malone, carries her generosity forward by supporting research for more cancer treatment options, like immunotherapy. bit.ly/4xA6AQJ
#OvarianCancerAwarenessMonth
Could a blood draw show whether #immunotherapy is working?
A @hopkinskimmel study led by CRI-funded scientist @ValsamoA found that a blood test may reveal a response in advanced lung cancer before scans do. bit.ly/4j3in6e
More on Dr. Anagnostou: bit.ly/4AsI3jf
